Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Clinical evolution

Clinical evolution

Randomised clinical trials have been the mainstay of pharmaceutical product development for decades, but will they be designed and carried out the same way in future? With trials tipped to get smaller and patient selection more complex as pharma’s blockbuster model is dismantled, interactive technologies, adaptive designs and new ways to recruit and monitor patients will come to the fore.

Struggling PharmaNet launches new flexible staffing service

05-Mar-2009 -  US CRO PharmaNet hopes its new trial staffing service will provide an additional revenue stream and help stave-off plummeting 2008 incomes and compensate for a series of painful contract cancellations.

Slowdown affecting rebranded eResearch Technology

04-Mar-2009 -  Cardiology and eClinical specialist eResearch Technology missed analysts estimates of sales and earnings in the fourth quarter of 2008, but still posted a near-14 per cent increase in operating profit. ...

Synexus opens new Bulgarian site for secondary care trials

26-Feb-2009 -  Synexus' new trial site in Bulgaria, which is part of the firm’s clinical research centre strategy, will help sponsors cut development times and significantly reduce costs, according to CEO Michael...

Kendle earnings hit by computer error

26-Feb-2009 -  Kendle International posted a 22 per cent drop in net income to $5m, after a computer error led to problems with a clinical trial carried out for one of its...

Trial sites call for more EDC and recruitment investment

19-Feb-2009 -  Study site operators want greater use of EDC technologies and more pharma industry investment to boost patient recruitment and reduce delays in clinical trials, according to an industry report due...

Bio-Imaging Tech dips into the red in Q4

18-Feb-2009 -  Contract research organisation Bio-Imaging Technologies posted a 48 per cent hike on revenues in the fourth quarter of 2008, but still made a small net loss on the back of...

etrials adds competitor Unithink to confidentiality case

16-Feb-2009 -  US software specialist etrials Worldwide has added Belgian rival Unithink to an ongoing lawsuit that accuses two former executives, Robert Sammis and Brendon Ball, of breaching confidentiality agreements.

Charles River cuts preclinical jobs in global gloom

12-Feb-2009 -  Charles River Laboratories will reduce its workforce by 3 per cent, close its preclinical facility in Arkansas, US and sell off its Phase I trial site in Edinburgh, Scotland as...

Compass points to excipient elimination through microfilling

11-Feb-2009 -  Compass Pharma Services is targeting contract drug developers and clinical research firms with a new microfilling offering that, it claims, helps reduce waste and may even make excipients unnecessary in...

Russia’s clinical sector on the up

09-Feb-2009 -  Russia approved 615 clinical trials last year, a 9 per cent increase over 2007, lending weight to the notion that the country is becoming a global hub for clinical testing.

PRA expands in Asia-Pacific

05-Feb-2009 -  US company PRA International has entered into a strategic collaboration with two contract research organizations (CROs) in Southeast Asia in order to tap the fast-growing clinical research market in the...

Covance expands in CEE, Middle East

05-Feb-2009 -  Covance has expanded its presence in central and eastern Europe and Middle East with the opening of offices in Ukraine, Slovakia and Israel. 

Azopharma phases in Phase 0 offering

02-Feb-2009 -  US contract development firm Azopharma has begun offering microdosing at its AvivoClin facility in Daytona Beach, Florida, joining market leaders like Xeleron and Covance in the Phase 0 trial sector.

Bio-Imaging Tech sells CapMed to focus on clinical

08-Jan-2009 -  Contract research organisation Bio-Imaging Technologies has decided to sell off its CapMed subsidiary in order to focus its efforts on its core business, providing imaging series to clinical investigators.

India a ‘hot’ destination for clinical trials

08-Jan-2009 -  The proportion of global clinical trials conducted In India is expected to more than double between 2007 and 2012, according to market research firm RNCOS.

ICTS unit will help pharma’s message reach doctors

06-Jan-2009 -  US contract research organisation Integrated Clinical Trial Services has set up a team that will help pharmaceutical companies communicate information on their products to the medical community.

New CEO at microdosing specialist Xceleron

18-Dec-2008 -  Dr. Michael Butler has joined Xceleron as chief executive bringing an end to a search to replace Prof Colin Garner, the firm’s founder, who is retiring from the post. ...

Keep clinical trial patients ‘in the loop’, say researchers

18-Dec-2008 -  There is no formal requirement to inform clinical trial participants of the results of the study, a situation which can leave them “confused, frustrated and, in some cases, lacking information...

Icon boosts bioanalytical presence through Prevalere buy

08-Dec-2008 - Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical...

Bilcare boosts clinical trial supply business in India

08-Dec-2008 -  India’s Bilcare has expanded its clinical trial materials business in its own market with the opening of new packaging and storage capacity at its facilities in Pune, India. ...

Quintiles gets bigger in cancer with TMD purchase

02-Dec-2008 -  Quintiles Transnational has boosted its array of services for companies developing cancer drugs via the purchase of Illinois, US-based firm Targeted Molecular Diagnostics.

Tigermed, OCT and LSK to set up global trials network

25-Nov-2008 -  Chinese CRO Tigermed Consulting has teamed up with Russian and South Korean counterparts OCT and LSK to establish a global clinical trials network and expand its geographic footprint. 

Azopharma adds microdosing to service portfolio

23-Oct-2008 -  Contract drug development company Azopharma Product Development has set up a new business unit to cater for companies wanting to run microdosing or so-called Phase 0 studies.

Multi-study advances HIV drug to Phase II quicker

21-Oct-2008 - Pharmaceutical Profiles of the UK has completed a groundbreaking study that bundles together a number of tests used to decide whether a drug development candidate is worth pursuing into...

Parexel sets up proof-of-concept unit

02-Oct-2008 -  Parexel International has expanded its early phase drug development capabilities with a unit focused specifically on proof of concept studies.

Key Industry Events

Interphex 2014

New York, NY 10001 / Conference and exhibition

Read more

Access all events listing